Trials / Not Yet Recruiting
Not Yet RecruitingNCT06645769
Na-Phenylbutyrate VAscular Trial
- Status
- Not Yet Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study will investigate if the drug sodium phenylbutyrate (NaPB) impacts blood pressure and vascular function in healthy volunteers and in patients with diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sodium Phenylbutyrate | will be compared to placebo |
| OTHER | Placebo | will be compared to NaPB |
Timeline
- Start date
- 2026-06-01
- Primary completion
- 2028-01-01
- Completion
- 2029-06-01
- First posted
- 2024-10-17
- Last updated
- 2026-03-12
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06645769. Inclusion in this directory is not an endorsement.